August 31, 2012 |
The Food and Drug Administration on Thursday approved a new drug, Linzess, to treat irritable bowel syndrome with constipation. The drug, known generically as linaclotide, speeds up bowel movements and reduces pain in many patients with the disorder. It is the second product on the market aimed at the population, following Amitiza (lubiprostone), which was approved in January 2006 but may have more side effects than Linzess. An estimated 15.3 million Americans suffer from irritable bowel syndrome with constipation, according to the National Institutes of Health, and about 63 million suffer from constipation.
December 23, 2002 |
Hypnosis has been so effective in treating irritable bowel syndrome that British researchers recently tested its usefulness for chronic indigestion. More than 100 people at the Wythenshawe Hospital in Manchester, England, were assigned to receive 12 30-minute sessions of either hypnotherapy, supportive therapy and a placebo medication, or medication (rantidine twice a day) over 16 weeks.
November 12, 2000
Re "FDA Minimized Issue of Lotronex's Safety," Nov. 2: It is untrue that Glaxo Wellcome and the FDA have not taken seriously reports of adverse events among women who have taken Lotronex. Both Glaxo Wellcome and the FDA apply the world's highest standards in our efforts to make innovative medicines available. We both have independently scrutinized the benefits and risks and have concluded that, in appropriate patients, Lotronex has a demonstrated benefit in the treatment of diarrhea-predominant irritable bowel syndrome, which can be severely incapacitating.
August 20, 2001 |
Novartis, Europe's third-biggest drug maker, needs to win U.S. approval for the experimental medicine Zometa to start turning around a 18% drop in shares this year, analysts and investors said. The Food and Drug Administration may rule today on the drug, designed to treat a life-threatening condition in which too much calcium enters the bloodstream. The U.S. agency has been reviewing additional data after last year deeming Zometa "approvable."
June 1, 2007
Re "You know what makes me sick?" Opinion, May 27 As a practicing gastroenterologist and a board member of the Celiac Disease Foundation, I find it unfortunate that Heather Abel accuses physicians of pushing pills after being bought off by drug companies. The failure to diagnose celiac disease is because of symptoms (if any) that are typically subtle and nonspecific, not because of a conspiracy between physicians and drug companies. Abel says her irritable bowel syndrome was treated with Celebrex, which caused ulcers.
December 8, 2003 |
Peppermint is approved in Europe for treating colds, coughs, dyspepsia and liver conditions. In this country, the hardy perennial is often found in herbal remedies for stomach ailments and is sold as a dietary supplement. The herb's main ingredient is menthol, but it also contains flavonoids such as limonene. * Uses: Some herbalists recommend the herb or its oil for colds, coughs and headaches. It's also sometimes used to ease upset stomachs, irritable bowel syndrome and indigestion.
October 22, 2001 |
The next time your gut goes to pieces after a meal, it may turn out that fruit was the source of all that digestive distress. Doctors have long recognized that lactose intolerance--an ability to digest milk sugar--is responsible for some of the irritable bowel syndrome that plagues about 10% of all Americans.
April 24, 2002 |
Government advisors heeded patients' pleas Tuesday that a drug for irritable bowel syndrome should be cleared for sale again--but with stringent restrictions to try to mitigate side effects that have hospitalized more than 160 people and killed seven.
April 16, 2007 |
I receive a lot of ads in the mail for Flora Source, a probiotic. Will it do everything the ads claim? PEARL Wildomar The product: If our bodies ran by majority rule, we'd all be slaves to bacteria. By some estimates, the average digestive tract contains 750 trillion bacteria -- enough to outnumber the human cells in your entire body by about 7 to 1.
October 9, 2000
If you want to understand the state of American health care, this carefully reported documentary from Pulitzer Prize-winning journalist Hedrick Smith does an admirable job of addressing the major issues of quality and affordability. Although the documentary is aired in a three-hour block, it is divided into four segments that explore regional differences in quality of care, the woes of people with chronic illness, the health maintenance organization model, and the uninsured.